I've only been looking into RCE recently, thinking maybe RECCE327 has potential but I'm so confused about where they are at in terms of the anticipated completion of their so-called 'Phase 1/2 study' and find this particularly off-putting as a potential investor. According to the register, some data was anticipated in October last year for a Phase 1 study. What happened with that? Does a Phase 2 study even exist? Can anyone enlighten me? I am happy to be wrong.
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-22
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.9M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 47.5¢ | 46.0¢ | $77.35K | 164.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49974 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 37899 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |